||Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 588 active entries
Rainham Road South
Dagenham, Essex, RM10 7XS, UK
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Argenta Discovery is a new United Kingdom-based company (established 2000) dedicated to the production of high-quality lead series, suitable for development as potential pharmaceuticals. Argenta scientists work under contract to convert hits and leads from high-throughput screening into validated patentable lead series. Argenta comprises a mix of scientists skilled in computer-aided drug design, medicinal and combinatorial chemistry, and assay development and automated biochemical screening, forming one team for the in vitro optimisation of candidates.
Argenta Discovery is also actively working on its own projects for which patentable lead series will be available for sale or license. Argenta has a contract with Imperial College of Science, Technology and Medicine in London for First Right of Refusal for targets from several research groups.
Last update of this entry: September 04, 2000
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking